An individual capital expenditure theme involving ongoing investment in the acquisition and renewal of molds, using funds raised through the capital increase. It covers mold investments made since 2021 and additional plans for 2026–2027.
Companies5How many companies write about this.
Threads5One company can carry more than one thread here.